NCT06675695View on ClinicalTrials.gov

Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases

Active, not recruitingOBSERVATIONAL
Enrollment

4,864

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

New use of osimertinib

New use of osimertinib described in electronic health records is used as the exposure.

DRUG

New use of erlotinib or gefitinib

"New use of standard of care described in electronic health records (erlotinib or gefitinib) dispensing claim is used as the reference."

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Brigham and Women's Hospital

OTHER

NCT06675695 - Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases | Biotech Hunter | Biotech Hunter